par Goldman, Serge 
;Schoutens, André ;Blocklet, Didier ;Dumarey, Nicolas ;Egrise, D.;Lipschutz, Brigitte ;Monclus, Michel ;Moreno Reyes, Mario Rodrigo ;Schmitz, F;Van Naemen, J;Wikler, David
Référence Revue médicale de Bruxelles, 23 Suppl 2, page (101-105)
Publication Publié, 2002
;Schoutens, André ;Blocklet, Didier ;Dumarey, Nicolas ;Egrise, D.;Lipschutz, Brigitte ;Monclus, Michel ;Moreno Reyes, Mario Rodrigo ;Schmitz, F;Van Naemen, J;Wikler, David Référence Revue médicale de Bruxelles, 23 Suppl 2, page (101-105)
Publication Publié, 2002
Article révisé par les pairs
| Résumé : | During the last 25 years, the clinical and experimental activity in nuclear medicine at Erasme hospital has been influenced by the implementation of positron emission tomography (PET) in 1990 as a method of brain functional investigation. The activity of the PET/biomedical cyclotron unit has been dedicated to various subjects in neurology, neurosciences, psychiatry, oncology and cardiology. This has been made possible by developments in radiochemistry. The radiochemistry laboratory has designed and produced original tracers such as 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)-methyl]guanine (FHPG), a tracer of viral thymidine kinase activity in gene therapy protocols. We have brought new applications of PET, such as its integration into stereotactic neurosurgical and radioneurosurgical techniques in order to improve their diagnostic and therapeutic performance in neurooncology. We have also conducted multiple studies on brain physiology and pathophysiology, in particular with the use of functional and metabolic brain mapping methods and the use of tracers of neurotransmission systems. The Department of nuclear medicine has also performed studies on bone metabolism and investigated in vivo imaging methods of infectious and immune processes. |
